Global Benign Prostatic Hyperplasia (BPH) Drugs Market Research Report 2024(Status and Outlook)

Global Benign Prostatic Hyperplasia (BPH) Drugs Market Research Report 2024(Status and Outlook)



Report Overview:

BPH is an enlarged prostate. The prostate goes through two main growth cycles during a man’s life. The first occurs early in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this second growth phase.

The Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size was estimated at USD 3459.80 million in 2023 and is projected to reach USD 4203.91 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.

This report provides a deep insight into the global Benign Prostatic Hyperplasia (BPH) Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Benign Prostatic Hyperplasia (BPH) Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Benign Prostatic Hyperplasia (BPH) Drugs market in any manner.

Global Benign Prostatic Hyperplasia (BPH) Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Eli Lilly

GlaxoSmithKline

Astellas Pharma

Sanofi

Pfizer

Abbott

Allergan

TEVA

Mylan

Novartis

Merck

Market Segmentation (by Type)

Alpha-Blocker

Phosphodiesterase Type-5 Inhibitors

Others

Market Segmentation (by Application)

Hospitals

Drugstores

Others

Geographic SegmentationNorth America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
    • Key Benefits of This Market Research:
    Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Benign Prostatic Hyperplasia (BPH) Drugs Market
  • Overview of the regional outlook of the Benign Prostatic Hyperplasia (BPH) Drugs Market:
    • Key Reasons to Buy this Report:
    Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
    • Customization of the Report

      In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

      Note: this report may need to undergo a final check or review and this could take about 48 hours.

      Chapter Outline

      Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

      Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Benign Prostatic Hyperplasia (BPH) Drugs Market and its likely evolution in the short to mid-term, and long term.

      Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

      Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

      Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

      Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

      Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

      Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

      Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

      Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

      Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

      Chapter 12 is the main points and conclusions of the report.

  • 1 Research Methodology and Statistical Scope
    1.1 Market Definition and Statistical Scope of Benign Prostatic Hyperplasia (BPH) Drugs
    1.2 Key Market Segments
    1.2.1 Benign Prostatic Hyperplasia (BPH) Drugs Segment by Type
    1.2.2 Benign Prostatic Hyperplasia (BPH) Drugs Segment by Application
    1.3 Methodology & Sources of Information
    1.3.1 Research Methodology
    1.3.2 Research Process
    1.3.3 Market Breakdown and Data Triangulation
    1.3.4 Base Year
    1.3.5 Report Assumptions & Caveats
    2 Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
    2.1 Global Market Overview
    2.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
    2.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Estimates and Forecasts (2019-2030)
    2.2 Market Segment Executive Summary
    2.3 Global Market Size by Region
    3 Benign Prostatic Hyperplasia (BPH) Drugs Market Competitive Landscape
    3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Manufacturers (2019-2024)
    3.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Manufacturers (2019-2024)
    3.3 Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Average Price by Manufacturers (2019-2024)
    3.5 Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Sales Sites, Area Served, Product Type
    3.6 Benign Prostatic Hyperplasia (BPH) Drugs Market Competitive Situation and Trends
    3.6.1 Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration Rate
    3.6.2 Global 5 and 10 Largest Benign Prostatic Hyperplasia (BPH) Drugs Players Market Share by Revenue
    3.6.3 Mergers & Acquisitions, Expansion
    4 Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Analysis
    4.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Analysis
    4.2 Market Overview of Key Raw Materials
    4.3 Midstream Market Analysis
    4.4 Downstream Customer Analysis
    5 The Development and Dynamics of Benign Prostatic Hyperplasia (BPH) Drugs Market
    5.1 Key Development Trends
    5.2 Driving Factors
    5.3 Market Challenges
    5.4 Market Restraints
    5.5 Industry News
    5.5.1 New Product Developments
    5.5.2 Mergers & Acquisitions
    5.5.3 Expansions
    5.5.4 Collaboration/Supply Contracts
    5.6 Industry Policies
    6 Benign Prostatic Hyperplasia (BPH) Drugs Market Segmentation by Type
    6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    6.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Type (2019-2024)
    6.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size Market Share by Type (2019-2024)
    6.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Price by Type (2019-2024)
    7 Benign Prostatic Hyperplasia (BPH) Drugs Market Segmentation by Application
    7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    7.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Sales by Application (2019-2024)
    7.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (M USD) by Application (2019-2024)
    7.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate by Application (2019-2024)
    8 Benign Prostatic Hyperplasia (BPH) Drugs Market Segmentation by Region
    8.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Region
    8.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Region
    8.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Region
    8.2 North America
    8.2.1 North America Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country
    8.2.2 U.S.
    8.2.3 Canada
    8.2.4 Mexico
    8.3 Europe
    8.3.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country
    8.3.2 Germany
    8.3.3 France
    8.3.4 U.K.
    8.3.5 Italy
    8.3.6 Russia
    8.4 Asia Pacific
    8.4.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales by Region
    8.4.2 China
    8.4.3 Japan
    8.4.4 South Korea
    8.4.5 India
    8.4.6 Southeast Asia
    8.5 South America
    8.5.1 South America Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country
    8.5.2 Brazil
    8.5.3 Argentina
    8.5.4 Columbia
    8.6 Middle East and Africa
    8.6.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales by Region
    8.6.2 Saudi Arabia
    8.6.3 UAE
    8.6.4 Egypt
    8.6.5 Nigeria
    8.6.6 South Africa
    9 Key Companies Profile
    9.1 Eli Lilly
    9.1.1 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.1.2 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.1.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.1.4 Eli Lilly Business Overview
    9.1.5 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs SWOT Analysis
    9.1.6 Eli Lilly Recent Developments
    9.2 GlaxoSmithKline
    9.2.1 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.2.2 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.2.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.2.4 GlaxoSmithKline Business Overview
    9.2.5 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs SWOT Analysis
    9.2.6 GlaxoSmithKline Recent Developments
    9.3 Astellas Pharma
    9.3.1 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.3.2 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.3.3 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.3.4 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs SWOT Analysis
    9.3.5 Astellas Pharma Business Overview
    9.3.6 Astellas Pharma Recent Developments
    9.4 Sanofi
    9.4.1 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.4.2 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.4.3 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.4.4 Sanofi Business Overview
    9.4.5 Sanofi Recent Developments
    9.5 Pfizer
    9.5.1 Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.5.2 Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.5.3 Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.5.4 Pfizer Business Overview
    9.5.5 Pfizer Recent Developments
    9.6 Abbott
    9.6.1 Abbott Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.6.2 Abbott Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.6.3 Abbott Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.6.4 Abbott Business Overview
    9.6.5 Abbott Recent Developments
    9.7 Allergan
    9.7.1 Allergan Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.7.2 Allergan Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.7.3 Allergan Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.7.4 Allergan Business Overview
    9.7.5 Allergan Recent Developments
    9.8 TEVA
    9.8.1 TEVA Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.8.2 TEVA Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.8.3 TEVA Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.8.4 TEVA Business Overview
    9.8.5 TEVA Recent Developments
    9.9 Mylan
    9.9.1 Mylan Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.9.2 Mylan Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.9.3 Mylan Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.9.4 Mylan Business Overview
    9.9.5 Mylan Recent Developments
    9.10 Novartis
    9.10.1 Novartis Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.10.2 Novartis Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.10.3 Novartis Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.10.4 Novartis Business Overview
    9.10.5 Novartis Recent Developments
    9.11 Merck
    9.11.1 Merck Benign Prostatic Hyperplasia (BPH) Drugs Basic Information
    9.11.2 Merck Benign Prostatic Hyperplasia (BPH) Drugs Product Overview
    9.11.3 Merck Benign Prostatic Hyperplasia (BPH) Drugs Product Market Performance
    9.11.4 Merck Business Overview
    9.11.5 Merck Recent Developments
    10 Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast by Region
    10.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size Forecast
    10.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast by Region
    10.2.1 North America Market Size Forecast by Country
    10.2.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size Forecast by Country
    10.2.3 Asia Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size Forecast by Region
    10.2.4 South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size Forecast by Country
    10.2.5 Middle East and Africa Forecasted Consumption of Benign Prostatic Hyperplasia (BPH) Drugs by Country
    11 Forecast Market by Type and by Application (2025-2030)
    11.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast by Type (2025-2030)
    11.1.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Drugs by Type (2025-2030)
    11.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size Forecast by Type (2025-2030)
    11.1.3 Global Forecasted Price of Benign Prostatic Hyperplasia (BPH) Drugs by Type (2025-2030)
    11.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast by Application (2025-2030)
    11.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (Kilotons) Forecast by Application
    11.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (M USD) Forecast by Application (2025-2030)
    12 Conclusion and Key Findings

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings